At TU Berlin, OpenAI CEO Sam Altman discussed about AI, GPT-5, and the future of technology in shaping the world.

GPT-4b, designed to enhance the efficiency of stem cell production. In collaboration with longevity startup Retro Biosciences, the Sam Altman-led company has trained this model to engineer ...

OpenAI’s new model, called GPT-4b micro, was trained to suggest ways to re-engineer the protein factors to increase their ...

OpenAI co-founder Sam Altman confirmed plans to develop an AI device. He hinted that this device will focus on voice commands. Altman also said OpenAI was developing its own silicon for AI devices.

The startup, which Sam Altman is an investor in ... or a set of proteins that can turn a human skin cell into a young stem cell. Stem cells can then morph into any type of cell in the human ...

OpenAI CEO Sam Altman has conceded that the company has ... but more than likely will be called GPT-5. There may also be an overhaul of the DALL-E 3 image generator, which hasn’t had a major ...

OpenAI, in partnership with Retro Biosciences, has recently made significant strides in human longevity research with the ...

In a flurry of posts shared on X on Sunday, OpenAI chief Sam Altman described Deep Research as being “like a superpower; experts on demand.” He said it can “go use the internet, do complex ...

It was founded with an investment of $180 million (about 28 billion yen) from OpenAI CEO Sam Altman ... iPS cells, so scientists around the world are researching new Yamanaka factors. GPT-4b ...